SCL

NORTHBROOK, Ill., July 8, 2026 /PRNewswire/ -- Stepan Company (NYSE: SCL) will issue its second quarter 2026 earnings results on Wednesday, July 29, 2026 at approximately 7:00 a.m. ET (6:00 a.m. CT). Supporting slides will be posted at approximately the same time on the Investors/Presentations page at www.stepan.com. The Company will hold a conference call to discuss and answer questions about its financial and operational performance on the same day at 9:00 a.m. ET (8:00 a.m. CT). The call will be hosted by Luis E. Rojo, President and Chief Executive Officer, and Ruben Velasquez, Vice President and Chief Financial Officer. The call can be accessed by phone and webcast. To access the call by phone, please click on this Registration Link, complete the form and you will be provided with dial in details and a PIN. To avoid delays, we encourage participants to dial into the conference call ten minutes ahead of the scheduled start time. The webcast can be accessed through the Investors/Conference Calls page at www.stepan.com. A webcast replay of the conference call will be available at the same location shortly after the call. Corporate ProfileStepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries. Stepan is a leading merchant producer of surfactants, which are the key ingredients in consumer and industrial cleaning and disinfection products and in agricultural and oilfield solutions. The Company is also a leading supplier of polyurethane polyols used in the expanding thermal insulation market, and CASE (Coatings, Adhesives, Sealants, and Elastomers) industries. Headquartered in Northbrook, Illinois, Stepan utilizes a network of modern production facilities located in North and South America, Europe and Asia. The Company's common stock is traded on the New York Stock Exchange (NYSE) under the symbol SCL. For more information about Stepan Company please visit the Company online at www.stepan.com. More information about Stepan's sustainability program can be found on the Sustainability page at www.stepan.com. Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements includ...

Image source: The Motley Fool. Tuesday, April 29, 2025 at 8:00 a.m. ET Chief Financial Officer — Luis Rojo Vice President & Controller — Sam Hinrichsen Luis Rojo: Thank you, Sam. Good morning and thank you all for joining us today to discuss our first quarter 2025 results. I plan to share highlights of the quarterly performance and will also share updates on our key strategic priorities while Sam will provide additional detail on our financial results. We are pleased with the start of 2025 and I'm proud of our team that is committed to further improving earnings going forward. The company reported first quarter adjusted EBITDA of $57.5 million, up 12% versus the prior year. Surfactant and Specialty Products delivered double-digit adjusted EBITDA growth while Polymers adjusted EBITDA decreased slightly year-over-year. Volume grew 4% and the growth was broad-based with Surfactants up 3%, Polymers up 7% and our MCT product line up 4%. We continue to experience double-digit volume growth within the agricultural and oil field end markets and with our distribution partners in Surfactants. North America and European Rigid Polyol volume grew single-digits while the Specialty Polyols and Commodity PA businesses delivered a strong growth year-over-year. We believe that Rigid Polyol growth in North America and Europe continues to be restrained by global macroeconomic uncertainties and the high interest rate environment. We're encouraged by the broad-based volume growth across several of our key strategic end markets. We finished the first quarter of 2025 with $19.3 million of adjusted net income, up 32% versus the prior year driven by earnings growth in Surfactants and Specialty Products and a lower tax rate. We executed the safe startup of our new Pasadena, Texas site, which is now operational. During the first quarter of 2025, the company paid $8.7 million in dividends to shareholders. Our Board of Directors declared a quarterly cash dividend on Stepan common stock of $0.385 per share payable on June 13, 2025. Stepan has paid an increased dividend for 57 consecutive years. Sam will now share some details about our first quarter results. Sam Hinrichsen: Thank you, Luis. My comments will generally follow the slide presentation. Let's start with Slide 4 to recap the quarter. First quarter 2025 adjusted net income was $19.3 million or $0.84 per diluted share versus $14.7...

Reported Q1 net loss of $41.4 million (‑$1.81/sh) was driven by a $65.4 million pre‑tax restructuring charge tied to site closures and asset decommissioning; on an adjusted basis net income fell to $10.3 million (‑47%), consolidated EBITDA declined 14%, free cash flow was negative $14 million, and net debt was $511 million (leverage 2.7x). Project Catalyst is expected to deliver about $100 million in pre‑tax savings over two years (≈60% in 2026) with the bulk of savings beginning to show in Q2, and the company agreed to sell non‑productive Millsdale land for $30 million (expected close in fall 2026). Segment dynamics: Surfactants faced margin pressure from lower absorption, Asia production timing issues and elevated oleochemical costs (driving a $7 million EBITDA decline) while Polymers delivered improved adjusted EBITDA despite lower sales; the Pasadena plant ramp to ~80% utilization in 2026 (full in 2027) should support specialty growth and margin recovery. Interested in Stepan Company? Here are five stocks we like better. 3 chemical stocks to play the industry breakout Stepan (NYSE:SCL) reported a first-quarter 2026 net loss as restructuring charges tied to its asset footprint changes overshadowed modest organic sales growth and mixed segment performance. Management also emphasized progress on its multi-year cost and asset optimization initiative, Project Catalyst, and discussed raw material inflation and supply constraints stemming from the Iran war. Vice President and Chief Financial Officer Ruben Velasquez said Stepan posted a reported net loss of $41.4 million, or $1.81 per diluted share, compared with net income of $19.7 million, or $0.86 per diluted share, in the prior-year quarter. Velasquez attributed the reported loss primarily to a $65.4 million pre-tax restructuring charge ($51.2 million after tax) related to the previously announced closure of the company’s Fieldsboro, New Jersey site and the decommissioning of select assets at its Millsdale, Illinois and Stalybridge, U.K. facilities. → Homebuilder Earnings: D.R. Horton Sticks Out as Pulte & NVR Sales Tank Velasquez noted the cash impact associated with the restructuring charge was less than $1 million during the quarter. On an adjusted basis, the company reported adjusted net income of $10.3 million, or $0.45 per diluted share, down 47% from adjusted net income of $19.3 million, or $0.84 per...

Image source: The Motley Fool. Tuesday, April 28, 2026 at 8 a.m. ET Chief Executive Officer — Luis Rojo Chief Financial Officer — Ruben Velasquez Luis Rojo: Thank you, Ruben. Good morning, and thank you all for joining us today to discuss our first quarter 2026 results. I plan to share highlights of the quarter's performance and provide an update on our key strategic priorities, while Ruben will provide additional details on our financial results. Before reviewing the quarter, I want to recognize our teams around the world for their continued commitment to safety and operational excellence. Safety remains our top priority and the foundation for everything we do at Stepan. That focus was evident as we delivered the strongest safety performance on record during the first quarter of this year. Congratulations, team. Q1 2026 was an important quarter of execution for Stepan. We advanced our footprint and asset base optimization efforts, delivered net sales growth in a challenging macro environment and continue to generate a strong volume growth across our strategic end markets. Organic net sales were up 4% year-over-year. Organic volume was flat with double-digit growth in Crop Productivity, Oilfield, Industrial Cleaning and in our Tier 2, Tier 3 customer base. This was offset by continued soft demand in European Polymers. Adjusted EBITDA was $50 million, down 14% versus the prior year, reflecting lower Surfactant results due to lower absorption and production timing issues in Asia, competitive pressures in Mexico, the impact of the U.S. cold snap and continued pressures from elevated oleochemical input costs. Polymers delivered an 8% increase in adjusted EBITDA, driven by 5% volume growth in North America and global margin improvement, which was partially offset by continued softness in Europe. Specialty Products delivered volume growth of 30%, reflecting a strong demand and new business with our MCT product line. EBITDA was slightly down due to product mix and lag on raw material prices. We continue to execute Project Catalyst safely on time and on budget. These actions demonstrate our disciplined approach to cost optimization while ensuring we maintain the capabilities needed to serve our customers and deliver balanced growth across our higher value end markets. We remain committed to a balanced approach with capital allocation. During the first quarter, the c...

Delivered 4% organic net sales growth despite a challenging macro environment, driven by double-digit volume expansion in Crop Productivity, Oilfield, and Industrial Cleaning. Adjusted EBITDA declined 14% primarily due to temporary production timing issues in Asia and lower absorption following a U.S. cold snap. Surfactant margins were pressured by elevated oleochemical input costs, specifically the unprecedented price delta between coconut oil (CNO) and palm kernel oil (PKO). Polymers segment performance was bifurcated, with 5% volume growth in North America spray foam offset by double-digit declines in the depressed European construction market. Specialty Products achieved 30% volume growth in the MCT product line, though EBITDA was slightly impacted by product mix and raw material price lags. Strategic focus on Tier 2 and Tier 3 customers is yielding results, as these value-oriented brands gain share from larger branded competitors in a high-inflation environment. Project Catalyst is expected to deliver approximately $100 million in pretax savings over two years, with 60% of those savings targeted for 2026. Management expects the Pasadena, Texas facility to reach 80% average utilization in 2026 and full utilization by 2027, driving significant supply chain savings. The company anticipates recovering approximately half of the $7 million Surfactant EBITDA headwind in subsequent quarters as production timing and absorption issues normalize. Pricing is expected to remain sticky as raw material inflation persists, supported by a more stable relationship between CNO and PKO prices. Capital allocation remains focused on deleveraging the balance sheet, with normal CapEx for base reliability and infrastructure targeted at around $100 million or less. Recorded a $65.4 million pretax restructuring charge related to the closure of the Hillsborough site and asset decommissioning at Millsdale and Stalybridge. Announced an agreement to sell nonproductive land at the Millsdale site for $30 million, with the transaction expected to close in the fall of 2026. Identified ongoing geopolitical risks, specifically the conflict in Iran, as a potential driver of raw material volatility and localized supply chain shortages. Lower capitalized interest income in Q1 reflected the operational start-up of the Pasadena site, impacting year-over-year pretax income comparisons. Our analy...

This article first appeared on GuruFocus. Release Date: April 28, 2026 For the complete transcript of the earnings call, please refer to the full earnings call transcript. Stepan Co (NYSE:SCL) achieved the strongest safety performance on record during the first quarter of 2026. Organic net sales increased by 4% year-over-year, with double-digit growth in crop productivity, oil field, industrial cleaning, and Tier 2 and Tier 3 customer bases. Polymers segment delivered an 8% increase in adjusted EBITDA, driven by 5% volume growth in North America and global margin improvement. Specialty products saw a 30% volume growth, reflecting strong demand and new business with the MCT product line. The company remains committed to shareholder returns, paying $8.9 million in dividends and declaring a quarterly cash dividend of $0.39.5 per share. Adjusted EBITDA decreased by 14% to $50 million, primarily due to lower surfactant results and higher interest expenses. Reported a net loss of $41.4 million for the quarter, impacted by a $65.4 million pre-tax restructuring charge related to site closures. Surfactant earnings were negatively affected by lower absorption and production timing issues in Asia, competitive pressures in Mexico, and higher raw material costs. Free cash flow was negative $14 million, driven by higher working capital requirements typical for the first quarter. The European market continues to face softness, particularly in the polymers segment, due to ongoing macroeconomic uncertainty and a depressed construction market. Warning! GuruFocus has detected 7 Warning Signs with SCL. Is SCL fairly valued? Test your thesis with our free DCF calculator. Q: What are the impacts of the Iran war on raw material costs and availability, and how is Stepan Co managing these challenges? A: Luis Rojo, President and CEO, explained that the Iran war has led to escalation in raw material inflation, particularly affecting the oil supply chain. Stepan Co has been successful in passing through price increases in line with raw material inflation due to their disciplined pricing process and pass-through contracts. However, raw material availability remains a challenge, impacting growth potential. The company is working closely with suppliers to ensure they receive a fair share of necessary materials. Q: How is Stepan Co positioned to gain market share amid the Iran war's impact...

Image source: The Motley Fool. Wednesday, July 30, 2025 at 9:00 a.m. ET Chief Financial Officer — Luis E. Rojo Chief Executive Officer — Ruben Velasquez Luis E. Rojo: Thank you, Ruben. Good morning, and thank you all for joining us today to discuss our second quarter 2025 results. Before we turn to business, I would like to welcome Ruben to his first Stepan conference earnings call, and I look forward to working together on our new journey of growth and transformation. I also want to extend my sincere appreciation to Sam for his dedication, steady leadership and contributions to the interim period. Thank you, Sam. Moving on, I plan to share highlights of the quarterly performance and we'll also share updates on our key strategic priorities, while Ruben will provide additional details on our financial results. We delivered double-digit adjusted EBITDA growth in the first half of 2025. These results were restrained by the significant increase in oleochemical's raw material prices, which impacted Surfactant margins. We are planning to recover our margins gradually going forward. The company reported second quarter adjusted EBITDA of $51.4 million, up 8% versus the prior year. Polymers delivered double-digit adjusted EBITDA growth. Surfactant-adjusted EBITDA was similar to last year, driven by excellent growth in our crop productivity business, fully offset by significant raw material inflation. Specialty Products adjusted EBITDA was impacted by order timing changes, and the business continues to deliver solid growth. Volume grew 1% with Polymers up 7% and our NCT product line up 49%, while surfactants volume was down 1%. We continue to experience double-digit volume growth within the crop productivity and oilfield end markets, which was offset by lower demand within the global commodity consumer products end market. North America and European Rigid Polyols volume grew low single digits, while the commodity PA business continues to deliver a strong growth year-over-year. We believe that Rigid Polyol growth in North America and Europe continues to be restrained by global macroeconomic uncertainties and the high interest rate environment. We remain encouraged by the volume growth across several of our key strategic end markets. We finished the second quarter of 2025 with $12 million of adjusted net income, up 27% versus the prior year, driven by earnings growth in...

NORTHBROOK, Ill., April 28, 2026 /PRNewswire/ -- Stepan Company (NYSE:SCL) today reported: The Board of Directors of Stepan Company has declared a quarterly cash dividend on the Company's common stock of $0.395 per share. The dividend is payable on June 15, 2026, to common stockholders of record on June 1, 2026. The Company increased its quarterly cash dividend in the fourth quarter of 2025 by $0.010 per share, marking the 58th consecutive year that the Company has increased its cash dividend to stockholders. Corporate Profile Stepan Company is a major manufacturer of specialty and intermediate chemicals used in a broad range of industries. Stepan is a leading merchant producer of surfactants, which are the key ingredients in consumer and industrial cleaning and disinfection products and in agricultural and oilfield solutions. The Company is also a leading supplier of polyurethane polyols used in the expanding thermal insulation market, and CASE (Coatings, Adhesives, Sealants, and Elastomers) industries. Headquartered in Northbrook, Illinois, Stepan utilizes a network of modern production facilities located in North and South America, Europe and Asia. The Company's common stock is traded on the New York Stock Exchange (NYSE) under the symbol SCL. For more information about Stepan Company please visit the Company online at www.stepan.com. More information about Stepan's sustainability program can be found on the Sustainability page at www.stepan.com. Certain information in this news release consists of forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995, Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These statements include statements about Stepan Company's plans, objectives, strategies, financial performance and outlook, trends, the amount and timing of future cash distributions, prospects or future events and involve known and unknown risks that are difficult to predict. As a result, Stepan Company's actual financial results, performance, achievements or prospects may differ materially from those expressed or implied by these forward-looking statements. In some cases, you can identify forward-looking statements by the use of words such as "may," "could," "expect," "intend," "plan," "seek," "anticipate," "believe," "estimate," "guida...

Stepan (SCL) reported Q1 adjusted earnings Tuesday of $0.45 per diluted share, down from $0.84 a yea

Stepan Co. (SCL) came out with quarterly earnings of $0.45 per share, beating the Zacks Consensus Estimate of $0.21 per share. This compares to earnings of $0.84 per share a year ago. These figures are adjusted for non-recurring items. This quarterly report represents an earnings surprise of +114.29%. A quarter ago, it was expected that this specialty chemicals company would post earnings of $0.35 per share when it actually produced a loss of $0.02, delivering a surprise of -105.71%. Over the last four quarters, the company has surpassed consensus EPS estimates two times. Stepan Co., which belongs to the Zacks Chemical - Diversified industry, posted revenues of $604.51 million for the quarter ended March 2026, missing the Zacks Consensus Estimate by 4.09%. This compares to year-ago revenues of $593.26 million. The company has topped consensus revenue estimates just once over the last four quarters. The sustainability of the stock's immediate price movement based on the recently-released numbers and future earnings expectations will mostly depend on management's commentary on the earnings call. Stepan Co. shares have added about 11.2% since the beginning of the year versus the S&P 500's gain of 4.8%. While Stepan Co. has outperformed the market so far this year, the question that comes to investors' minds is: what's next for the stock? There are no easy answers to this key question, but one reliable measure that can help investors address this is the company's earnings outlook. Not only does this include current consensus earnings expectations for the coming quarter(s), but also how these expectations have changed lately. Empirical research shows a strong correlation between near-term stock movements and trends in earnings estimate revisions. Investors can track such revisions by themselves or rely on a tried-and-tested rating tool like the Zacks Rank, which has an impressive track record of harnessing the power of earnings estimate revisions. Ahead of this earnings release, the estimate revisions trend for Stepan Co. was unfavorable. While the magnitude and direction of estimate revisions could change following the company's just-released earnings report, the current status translates into a Zacks Rank #5 (Strong Sell) for the stock. So, the shares are expected to underperform the market in the near future. You can see the complete list of today's Zacks #1 R...

NORTHBROOK, Ill. (AP) — NORTHBROOK, Ill. (AP) — Stepan Co. (SCL) on Tuesday reported a loss of $41.4 million in its first quarter. The Northbrook, Illinois-based company said it had a loss of $1.81 per share. Earnings, adjusted for restructuring costs and non-recurring costs, were 45 cents per share. The specialty chemicals company posted revenue of $604.5 million in the period. _____ This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on SCL at https://www.zacks.com/ap/SCL

NORTHBROOK, Ill., April 28, 2026 /PRNewswire/ -- Stepan Company (NYSE: SCL) today reported: First Quarter 2026 Highlights Reported net income was a $41.4 million loss versus $19.7 million of income in the prior year. The current year loss resulted from a previously announced $65.4 million pre-tax restructuring charge. Adjusted net income(1) was $10.3 million, down 47% versus the prior year, largely due to lower Surfactant earnings and higher interest expense. The higher interest expense reflects lower capitalized interest income due to the start-up of the Pasadena, TX site. EBITDA(2) was a negative $16.5 million versus $58.0 million in the prior year. Current year EBITDA was negatively impacted by the $65.4 million restructuring charge. Adjusted EBITDA(2) was $49.6 million, down 14% year-over-year. Organic sales volume was flat year-over-year as strong demand within Crop Productivity, Oilfield and Industrial Cleaning was offset by soft European Polymers demand. Cash from Operations was $16.9 million during the quarter. Free cash flow(3) for the quarter was a negative $14.0 million, driven by higher working capital requirements which are typical during the first quarter. Pre-tax earnings include a $65.4 million restructuring charge related to the previously announced closure of the Company's Fieldsboro, NJ site and select assets at its Elwood (Millsdale), IL and Stalybridge, UK facilities. The cash impact associated with this restructuring charge was less than $1.0 million during the quarter. The Company has entered into an agreement to sell a parcel of land near its Millsdale site for $30 million. This agreement is subject to customary closing conditions and the transaction is expected to close during the second half of the year. "We are executing Project Catalyst safely and in line with expectations despite early quarter weather-related impacts and the new geopolitical challenges. Global adjusted EBITDA was down $7.9 million, or 14%, driven by our Surfactants business. Surfactants EBITDA was down due to higher oleochemicals prices, the cold snap in the U.S., production timing differences in Asia along with competitive pressures in Mexico. Polymers adjusted EBITDA grew 8% on the strength of North American volume growth and margin recovery that more than offset ongoing challenges within the European business. Specialty Products volume was up 30% versus prior...